Beneficial Effects of <i>Akkermansia muciniphila</i> Are Not Associated with Major Changes in the Circulating Endocannabinoidome but Linked to Higher Mono-Palmitoyl-Glycerol Levels as New PPARα Agonists

Beneficial Effects of <i>Akkermansia muciniphila</i> Are Not Associated with Major Changes in the Circulating Endocannabinoidome but Linked to Higher Mono-Palmitoyl-Glycerol Levels as New PPARα Agonists

<i>Akkermansia muciniphila</i> is considered as one of the next-generation beneficial bacteria in the context of obesity and associated metabolic disorders. Although a first proof-of-concept of its beneficial effects has been established in the context of metabolic syndrome in humans, me...

Full description

Bibliographic Details
Main Authors: Clara Depommier, Rosa Maria Vitale, Fabio Arturo Iannotti, Cristoforo Silvestri, Nicolas Flamand, Céline Druart, Amandine Everard, Rudy Pelicaen, Dominique Maiter, Jean-Paul Thissen, Audrey Loumaye, Michel P. Hermans, Nathalie M. Delzenne, Willem M. de Vos, Vincenzo Di Marzo, Patrice D. Cani
Format: Article
Language:English
Published: MDPI AG 2021-01-01
Series:Cells
Subjects:
endocannabinoids
endocannabinoidome
<i>Akkermansia muciniphila</i>
human
metabolic syndrome
obesity
Online Access:https://www.mdpi.com/2073-4409/10/1/185

Internet

https://www.mdpi.com/2073-4409/10/1/185

Similar Items